Paolo Martini

Chief Research & Development Officer ReAlta Life Sciences: advancing the current pipeline and unlocking new opportunities for different therapeutic areas

Paolo Martini is the Chief Research & Development Officer at ReAlta Life Sciences, based in Cambridge, Massachusetts. He has an extensive background in molecular biology and drug development, with a Ph.D. from Università degli Studi di Milano.

Professional Experience

Chief Scientific Officer at Moderna (December 2022 - Present)
CSO Rare Diseases, Hematology, and External R&D at Moderna (October 2020 - December 2022)
Senior Director of Discovery Biology at Shire HGT (February 2013 - September 2015)
Director of Discovery Biology at Shire HGT (April 2011 - February 2013)
Director of Molecular Biology at Shire HGT (February 2010 - April 2011)
Group Leader at Serono Research Institute (June 2001 - June 2006)

Academic Background

Ph.D. in Molecular Biology, Università degli Studi di Milano

Skills and Expertise

Martini specializes in drug discovery and development, particularly focusing on rare genetic diseases and antibody therapeutics. His leadership roles have involved overseeing research pipelines and collaborating with business development teams to identify new therapeutic assets.

Languages

Fluent in Italian and English

His career reflects a strong commitment to advancing biopharmaceutical research and development through innovative approaches and strategic leadership.